Literature DB >> 11024024

Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans.

M Tyagi1, M Rusnati, M Presta, M Giacca.   

Abstract

Tat, the transactivator protein of human immunodeficiency virus-1, has the unusual capacity of being internalized by cells when present in the extracellular milieu. This property can be exploited for the cellular delivery of heterologous proteins fused to Tat both in cell culture and in living animals. Here we provide genetic and biochemical evidence that cell membrane heparan sulfate (HS) proteoglycans act as receptors for extracellular Tat uptake. Cells genetically defective in the biosynthesis of fully sulfated HS are selectively impaired in the internalization of recombinant Tat fused to the green fluorescent protein, as evaluated by both flow cytometry and functional assays. In wild type cells, Tat uptake is competitively inhibited by soluble heparin and by treatment with glycosaminoglycan lyases specifically degrading HS chains. Cell surface HS proteoglycans also mediate physiological internalization of Tat green fluorescent protein released from neighboring producing cells. In contrast to extracellular Tat uptake, both wild type cells and cells genetically impaired in proteoglycan synthesis are equally proficient in the extracellular release of Tat, thus indicating that proteoglycans are not required for this process. The ubiquitous distribution of HS proteoglycans is consistent with the efficient intracellular delivery of heterologous proteins fused with Tat to different mammalian cell types.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11024024     DOI: 10.1074/jbc.M006701200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  196 in total

1.  Tat-neutralizing antibodies in vaccinated macaques.

Authors:  Ilia Tikhonov; Tracy J Ruckwardt; Glen S Hatfield; C David Pauza
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Analysis of protein kinase A activity in insulin-secreting cells using a cell-penetrating protein substrate and capillary electrophoresis.

Authors:  Femina Rauf; Yiding Huang; Thusitha P Muhandiramlage; Craig A Aspinwall
Journal:  Anal Bioanal Chem       Date:  2010-05-12       Impact factor: 4.142

3.  Fibroblast growth factor-12 (FGF12) translocation into intestinal epithelial cells is dependent on a novel cell-penetrating peptide domain: involvement of internalization in the in vivo role of exogenous FGF12.

Authors:  Fumiaki Nakayama; Takeshi Yasuda; Sachiko Umeda; Masahiro Asada; Toru Imamura; Viktor Meineke; Makoto Akashi
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

4.  Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter.

Authors:  Marina Lusic; Alessandro Marcello; Anna Cereseto; Mauro Giacca
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

5.  HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses.

Authors:  Agnès Vendeville; Fabienne Rayne; Anne Bonhoure; Nadir Bettache; Philippe Montcourrier; Bruno Beaumelle
Journal:  Mol Biol Cell       Date:  2004-03-12       Impact factor: 4.138

Review 6.  Cell penetrating peptides in drug delivery.

Authors:  Eric L Snyder; Steven F Dowdy
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

7.  Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions.

Authors:  Abhijit Mishra; Ghee Hwee Lai; Nathan W Schmidt; Victor Z Sun; April R Rodriguez; Rong Tong; Li Tang; Jianjun Cheng; Timothy J Deming; Daniel T Kamei; Gerard C L Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

8.  Characterization of the cell-penetrating properties of the Epstein-Barr virus ZEBRA trans-activator.

Authors:  Romy Rothe; Lavinia Liguori; Ana Villegas-Mendez; Bruno Marques; Didier Grunwald; Emmanuel Drouet; Jean-Luc Lenormand
Journal:  J Biol Chem       Date:  2010-04-09       Impact factor: 5.157

9.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

Review 10.  Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications.

Authors:  Allison H Bartlett; Pyong Woo Park
Journal:  Expert Rev Mol Med       Date:  2010-02-01       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.